Casper Pharma Llc Drug Patent Portfolio
Casper Pharma Llc owns 2 orange book drugs protected by 1 US patent Given below is the list of Casper Pharma Llc's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7091236 | Method for increasing the bioavailability of glycopyrrolate | 24 Apr, 2024 | Expired |
Latest Legal Activities on Casper Pharma Llc's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Casper Pharma Llc.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 09 Feb, 2018 | US7091236 (Litigated) |
| Payment of Maintenance Fee, 12th Year, Large Entity | 09 Feb, 2018 | US7091236 (Litigated) |
|
Email Notification
Critical
| 13 Dec, 2012 | US7091236 (Litigated) |
|
Email Notification
Critical
| 13 Dec, 2012 | US7091236 (Litigated) |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 13 Dec, 2012 | US7091236 (Litigated) |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 13 Dec, 2012 | US7091236 (Litigated) |
|
Correspondence Address Change
Critical
| 12 Dec, 2012 | US7091236 (Litigated) |
|
Correspondence Address Change
Critical
| 12 Dec, 2012 | US7091236 (Litigated) |
|
Email Notification
Critical
| 30 Aug, 2011 | US7091236 (Litigated) |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 30 Aug, 2011 | US7091236 (Litigated) |
|
Email Notification
Critical
| 30 Aug, 2011 | US7091236 (Litigated) |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 30 Aug, 2011 | US7091236 (Litigated) |
|
Correspondence Address Change
Critical
| 26 Aug, 2011 | US7091236 (Litigated) |
|
Correspondence Address Change
Critical
| 26 Aug, 2011 | US7091236 (Litigated) |
|
Patent Issue Date Used in PTA Calculation
Critical
| 15 Aug, 2006 | US7091236 (Litigated) |
Casper Pharma Llc's Family Patents
Casper Pharma Llc Drug List
Given below is the complete list of Casper Pharma Llc's drugs and the patents protecting them.
1. Robinul
Robinul is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7091236 | Method for increasing the bioavailability of glycopyrrolate |
24 Apr, 2024
(7 months ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Robinul's drug page
2. Robinul Forte
Robinul Forte is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7091236 | Method for increasing the bioavailability of glycopyrrolate |
24 Apr, 2024
(7 months ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Robinul Forte's drug page